Accolade downgraded to Market Perform from Outperform at Leerink

Leerink downgraded Accolade (ACCD) to Market Perform from Outperform with a price target of $7.03, down from $9.50, after the company agreed to an acquisition by Transcarent. The firm views the deal as “logical both operationally and strategically,” the analyst tells investors.